Novartis was known as a global pharmaceutical, not a technology company. But that needed to change if it was going to realise the ambitious data and digital strategy that underpinned its roadmap to future success.
A commitment to data science and digital technologies was enshrined in Novartis' five key strategic pillars, along with a promise to embrace advanced analytics and artificial intelligence. And yet Novartis knew that technology meant nothing without t, recast Novartis as the go-to destination for top tech talent? How would this be the vehicle for a narrative that made clear: tech alone is not revolutionising medicine, but a powerful combination of brilliant biologists, chemists, clinicians and business minds, together with advanced technology and the untapped potential of data … this reimagining medicine.